Celltrion, Inc. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00620 filed by Celltrion, Inc. on 2023-02-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00620

Filing Date

2023-02-28

Accorded Filing Date

2023-02-28

Institution Decision Date

2023-09-01

Last Modified Date

—

Proceeding Type

IPR

Termination Date

2023-09-01

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Celltrion, Inc.

Represented By

Green, Loraet al

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Fishman, Deborahet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15692893

Respondent Patent Number 10406226

External Links

Espacenet

Google Patents

Respondent Inventor Daniel B. DIX et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)

Customer Number 191459

Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
41408	David Marsh	202-942-5068
48001	Thomas Triolo	914-847-1612
48921	Stephen Gaudet	914-847-7376
50370	Neil Miyamoto	914-847-7175
50437	Frank Cottingham	914-593-1116
58583	Brian Cocca	914-847-1421
58714	Ilona Gont	914-847-1304
59668	Brandon Schurter	914-847-7000
60281	Aparna Patankar	914-847-5571
61391	Yonghao Hou	914-839-2555
61915	Yongjin Choi	914-847-5384
65789	Margarita Zippin	914-847-5589
65957	Lisa Flanagan	914-847-8175
67881	Eileen Woo	914-847-1246
68046	Elysa Goldberg	914-847-1280
68059	David Mellman	720-391-8767
68136	Christopher Westberg	914-847-7912
71406	Gabriele Amodeo	914-847-3578
73212	Trisha Agrawal	914-313-7694
74751	Casey Donahoe	814-931-8622
76829	Michael Lewis	202-942-6728
77536	Alyson Nickols	640-448-3073
81783	Alice Ho	202-942-6753

Proceeding Documents

Institution Decision: Deny DECISION

2023-09-01 FILING PARTY: BOARD

Download

Patent Owner's Unopposed Motion to Terminate Proceeding MOTION

2023-08-08 FILING PARTY: PATENT OWN

Download

2001

Statutory Disclaimer Exhibit

2023-08-08 FILING PARTY: PATENT OWN

Download

Petitioner Updated Power of Attorney NOTICE

2023-05-01 FILING PARTY: PETITIONER

Download

Petitioner Updated Mandatory Notices NOTICE

2023-05-01 FILING PARTY: PETITIONER

Download

Celltrion, Inc. vs. Regeneron Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Celltrion, Inc.

Represented By

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Institution Decision: Deny DECISION

Patent Owner's Unopposed Motion to Terminate Proceeding MOTION

Statutory Disclaimer Exhibit

Petitioner Updated Power of Attorney NOTICE

Petitioner Updated Mandatory Notices NOTICE

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

EX1006 Corrected Holash et al. 2002 Exhibit

Notice: Notice filing date accorded NOTICE

Part 2 - U.S. Patent No. 7,374,758 patent term extension Exhibit

Robert Fahrner et al., 2001 Exhibit

Scheduling order in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceutical Exhibit

Y Mimura et al, 2001 Exhibit

Seq. alignment of SEQ ID NO. 4 from ’226 pat. and Figs. 24A-24C of ’319 Pub Exhibit

Regeneron’s Stipulation Regarding Case Narrowing And Injunctive Relief Exhibit

Dr. Peter Tessier Declaration Exhibit

S Krapp et al, 2003 Exhibit

Notice : Power of Attorney NOTICE

FDA PTC 1997 Exhibit

Jocelyn Holash et al., 2002 Exhibit

Florian Wurm, 2004 Exhibit

Christine Wulff et al., 2002 Exhibit

Liming Liu 2015 Exhibit

Petition : as filed PETITION

U.S. Patent No. 10,406,226 Exhibit

Portions of prosecution history for U.S. Patent No. 10,406,226 Exhibit

International Publication No. WO 0075319 A1 to Papadopoulos et al. Exhibit

Part 1 - U.S. Patent No. 7,374,758 patent term extension Exhibit

U.S. Publication No. 20040265309 A1 Exhibit

J.S. Rudge et al., 2005 Exhibit

U.S. Publication No. 20170360930 Exhibit

U.S. Patent No. 7,374,758 Exhibit

Dr. Peter Tessier curriculum vitae. Exhibit

U.S. Publication No. 20040014667 A1 Exhibit

Sequence alignment of SEQ ID NO: 2 and SEQ ID: NO 4 from ’226 patent Exhibit

Seq. alignment of SEQ ID NO 2 from ’226 pat. and Figs. 21A-21C of ’319 Pub Exhibit

Royston Jefferis 2005 Exhibit

Chang, B.S. and Hershenson, S., 2002 Exhibit

Provisional Patent Application No. 60665125 Exhibit

Napoleone Ferrara and Robert Kerbel, 2005 Exhibit